P25787 (PSA2_HUMAN) Homo sapiens (Human)

Proteasome subunit alpha type-2 UniProtKBInterProSTRINGInteractive Modelling

234 aa; Sequence (Fasta) ; 106 identical sequences

Available Structures

104 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
The human 26S Proteasome at 6.8 Ang. Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
1-234
100
Human 19S-20S proteasome, state SD2 Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
1-234
100ATP;LDZ;ZN;
Human premature 20S proteasome assembly intermediate Heteromer
O14818; O95456; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
1-234
100
Human Constitutive 20S Proteasome Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
2-234
100
Crystal Structure of the mammalian 20S proteasome at 2.75 A resolution Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
2-234
10030×MG;
Human constitutive 20S proteasome in complex with carfilzomib Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
2-234
1003BV;
The human PI31 complexed with bovine 20S proteasome Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3SX30; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
1-233
100
The PI31-free Bovine 20S proteasome Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
1-233
100
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
2-234
100ATP;ZN;
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
2-234
100ATP;ZN;
Human pre 13S proteasome assembly intermediate Heteromer
O14818; O95456; P25786; P25788; P25789; P28066; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
1-233
100
Human mixed 13S proteasome assembly intermediate Heteromer
O14818; O95456; P25786; P25788; P25789; P28066; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
2-234
100
The human 26S proteasome at 3.9 A Heteromer
O14818; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P49720; P49721; P60900; P62191; P62195; P62333; Q99436;
2-234
100ATP;MG;ADP;
Structure of the human 26S proteasome bound to USP14-UbAl Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
2-234
100ADP;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
3-234
100
Proteasome-ZFAND5 Complex Z+B state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
SD-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;AGS;
Proteasome-ZFAND5 Complex Z-C state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ADP;ZN;
Proteasome-ZFAND5 Complex Z+A state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Human 20S proteasome assembly intermediate structure 5 Heteromer
O14818; O95456; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
3-234
100
Structure of human constitutive 20S proteasome complexed with the inhibitor TDI-8304 Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
3-234
100YRE;
Proteasome-ZFAND5 Complex Z-A state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;
Proteasome-ZFAND5 Complex Z+C state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Proteasome-ZFAND5 Complex Z+E state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SC_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;ADP;ZN;
SA-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG48; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;AGS;MG;ADP;
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SB_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;ADP;ZN;
Structure of USP14-bound human 26S proteasome in state EA1_UBL Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;MG;ADP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SD4_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ADP;ATP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-inhibited state SD5_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;ADP;ZN;
Proteasome-ZFAND5 Complex Z-B state Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;
Structure of USP14-bound human 26S proteasome in state EA2.0_UBL Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;MG;ADP;ZN;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;AGS;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ADP;ATP;MG;
Structure of USP14-bound human 26S proteasome in state EA2.1_UBL Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;MG;ADP;ZN;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;AGS;
Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;AGS;
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;AGS;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED4_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ADP;ATP;ZN;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED1_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;ADP;ZN;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;ADP;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED2.0_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;ADP;ZN;
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED2.1_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;MG;ADP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED0_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;ADP;ZN;
Structure of USP14-bound human 26S proteasome in substrate-engaged state ED5_USP14 Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ATP;ADP;ZN;
Proteasome-ZFAND5 Complex Z+D state Heteromer
O00231; O00232; O00487; O14818; O43242; O76080; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
3-234
100ZN;ATP;MG;ADP;
Nub1/Fat10-processing human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P25786; P25788; P25789; P28066; P35998; P43686; P48556; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; Q9Y5A7;
3-234
100MG;ATP;ADP;ZN;
bovine 20S immunoproteasome Heteromer
P33672; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
4-234
100
Human 20S proteasome assembly intermediate structure 2 Heteromer
O14818; O95456; P25786; P25788; P25789; P28066; P49720; P60900; Q969U7; Q99436; Q9Y244;
3-233
100
Akirin2 bound human proteasome Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q53H80; Q99436;
3-233
100K;
Native human 20S proteasome at 1.8 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
10057×CL;1PE;K; 10×MG;
Human 20S proteasome complex with Oprozomib at 1.9 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
10058×CL;K; 10×MG;1PE;
Human 20S proteasome complex with Delanzomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
10052×CL;K; 10×MG;1PE;6V7;
Human 20S proteasome complex with Ixazomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
10051×CL;K; 10×MG;1PE;6V8;
Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
10056×CL;K; 10×MG;1PE;6VC;
Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
10055×CL;NEN;K; 10×MG;1PE;
Human 20S proteasome complex with Bortezomib at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
10051×CL;K; 10×MG;1PE;BO2;
Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
100K; 10×MG;1PE;ACT;
Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
100K;MG;1PE;
Human 20S proteasome complex with Epoxomicin at 2.4 Angstrom Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
10058×CL;K; 10×MG;1PE;
Human PA200-20S proteasome with MG-132 Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
4-233
100LDZ;IHP;
Endogeneous native human 20S proteasome Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-233
100
Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively … Heteromer
O14818; P20618; P25786; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
4-233
100BZ7;
Human 20S proteasome assembly intermediate structure 3 Heteromer
O14818; O95456; P25786; P25788; P25789; P28066; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
4-233
100
human PA200-20S complex Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
4-233
100K0W;IHP;
PA28alpha-beta in complex with immunoproteasome Heteromer
P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46;
5-234
100
Human PA200-20S proteasome complex Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
4-233
100IHP;
Human 26S proteasome in complex with Oprozomib Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q15008; Q99436; Q99460; Q9UNM6;
4-233
100ADP;
Non-substrate-engaged human 26S proteasome with Nub1/FAT10 bound to Rpn1 Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P25786; P25788; P25789; P28066; P35998; P43686; P48556; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6; Q9Y5A7;
5-234
100ADP;MG;ATP;ZN;
Human 20S Proteasome in complex with peptide activator peptide BLM42 Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-232
10054×CL; 10×MG;1PE;K;
HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [(1R)-2-(1-benzofuran-3-yl)-1-{[(1S,2R,4R)-7-ox… Heteromer
O14818; P20618; P25786; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
5-233
10013×NA; 11×SCN;S5K;
HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [2-(3-ethylphenyl)-1-[(2S)-3-phenyl-2-[(pyrazin… Heteromer
O14818; P20618; P25786; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
5-233
100SO4;NA;SKN;
Human Immunoproteasome 20S particle in complex with compound 1 Heteromer
O14818; P20618; P25786; P25788; P25789; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
5-233
100SCN; 12×NA;HUJ;
Human 20S proteasome with MG-132 Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-232
100LDZ;
human 20S proteasome Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-232
100
Human 20S proteasome core particle Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-232
100
20S+monoUb-CyclinB1-NT (S2) Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-232
100
Human 20S Proteasome Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
4-232
100
Human PA28-20S proteasome complex Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46;
4-232
100
Human 20S proteasome assembly intermediate structure 4 Heteromer
O14818; O95456; P20618; P25786; P25788; P25789; P28066; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
5-233
100
Human PA28-20S-PA28 proteasome complex Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46;
4-232
100
Human PA28-20S (PA28-4a3b) Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q06323; Q99436; Q9UL46;
4-232
100
Human preholo proteasome 20S core particle Heteromer
O14818; O95456; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q969U7; Q99436; Q9Y244;
4-232
100
Human proteasome 20S core particle Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
5-233
100
Structure of human 20S proteasome with bound MPI-5 Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
5-233
100YHD;
20S+monoUb-CyclinB1-NT (S1) Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
5-232
100
Bovine 20S immunoproteasome in complex with two human PA28alpha-beta activators Heteromer
P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46;
7-234
100
Bovine 20S proteasome, untreated Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
5-232
100
Human 20S proteasome assembly structure 1 Heteromer
O14818; O95456; P25786; P25788; P25789; P28066; P60900; Q5JS54; Q969U7; Q99436; Q9BT73; Q9Y244;
6-233
100
Human proteasome alpha ring assembly intermediate Heteromer
O14818; O95456; P25786; P25788; P25789; P28066; P60900; Q5JS54; Q969U7; Q9BT73;
5-232
100
Human 20S proteasome bound to an engineered 11S (PA26) activator Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; Q9U8G2;
8-234
100
canine immunoproteasome 20S subunit in complex with compound 1 Heteromer
A0A8C0M3N7; A0A8C0MRG6; A0A8C0N5D2; A0A8C0NHD1; A0A8C0QE86; A0A8C0QRK5; A0A8C0R9W7; A0A8C0SLB3; A0A8C0SR54; A0A8C0TD63; A0A8C0TIY6; A0A8I3PML0; Q5W412; Q5W416;
5-230
100A1L0C;
canine immunoproteasome 20S subunit in complex with compound 2 Heteromer
A0A8C0M3N7; A0A8C0MRG6; A0A8C0N5D2; A0A8C0NHD1; A0A8C0QE86; A0A8C0QRK5; A0A8C0R9W7; A0A8C0SLB3; A0A8C0SR54; A0A8C0T7K4; A0A8C0TD63; A0A8C0TIY6; A0A8I3PML0; Q5W416;
5-230
100A1L0D;
Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
6-227
100.0KNM;
Human 20S-PA200 Proteasome Complex Heteromer
O14818; P20618; P25786; P25788; P25789; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
19-232
100IHP;K0W;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7w38.1.Gmonomer0.863-234
100.00